Skip to main content

Table 2 Toxicities (n = 54 patients). (toxicities shown as worst episode per therapy)

From: Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study

Toxicity WHO grade
  I II III IV
Nausea/Vomiting 1 (1.8%) 13 (24.1%) 1 (1.9%) -
Neutropenia - 4 (7.4%) 14 (25.9%) 5 (9.3%)
Thrombocytopenia - 5 (9.3%) 2 (3.7%) -
Anaemia 18 (33.3%) 7 (13%) 6 (11.1%) -
Diarrhoea - 4 (7.4%) - -
Stomatitis - 2 (3.7%) 2 (3.7%) -
Polyneuropathia 1 (1.8%) 2 (3.7%) - -
Hand-Foot-Syndrom 3 (5.6%) 10 (18.1%) 3 (5.6%) -